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Background: Unicameral bone cyst (UBC) is the most common benign lytic bone lesion seen in children. The aim
of this study is to investigate clinical factors affecting pathological fracture and healing of UBC.
Methods: We retrospectively reviewed 155 UBC patients who consulted Nagoya musculoskeletal oncology group
hospitals in Japan. Sixty of the 155 patients had pathological fracture at presentation. Of 141 patients with
follow-up periods exceeding 6 months, 77 were followed conservatively and 64 treated by surgery.
Results: The fracture risk was significantly higher in the humerus than other bones. In multivariate analysis,
ballooning of bone, cyst in long bone, male sex, thin cortical thickness and multilocular cyst were significant
adverse prognostic factors for pathological fractures at presentation. The healing rates were 30% and 83% with
observation and surgery, respectively. Multivariate analysis revealed that fracture at presentation and history of
biopsy were good prognostic factors for healing of UBC in patients under observation.
Conclusion: The present results suggest that mechanical disruption of UBC such as fracture and biopsy promotes
healing, and thus watchful waiting is indicated in these patients, whereas patients with poor prognostic factors for
fractures should be considered for surgery.
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Unicameral bone cyst (UBC) is a benign bone lesion that
affects children and young persons. This lesion has been
reported together with aneurysmal bone cyst (ABC) [1].
USP6 and CDH11 oncogenes were reported to be identi-
fied in primary ABC [2], whereas the etiology of UBC
remains unclear. Various pathogenetic mechanisms have
been proposed including mechanical trauma, inflamma-
tion, and venous obstruction in the bone [3,4].
Because of the benign nature of UBC, the primary pur-
pose of treatment is prevention of pathological fracture.
Some reports have identified risk factors of pathological
fractures. Previous reports indicated that high cyst index
(area of the cyst/diaphysis diameter2) [5], high percent of
bone occupied by the cyst in the transverse plane [6], thin
cortical thickness [7], and location in the upper limb [8]* Correspondence: urakawa@med.nagoya-u.ac.jp
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unless otherwise stated.significantly increased the incidence of pathological frac-
tures. Although paradoxical, cyst healing was associated
with the occurrence of pathological fractures. Previous re-
ports showed that UBC healed spontaneously after frac-
tures [6,9]. Other reports demonstrated that fracture [10],
small cyst volume [10], cyst index [5], and long distance
from the growth plate [11] significantly increased the rate
of UBC healing after treatment.
The first aim of this study was to identify the risk factors
associated with the occurrence of pathological fracture,
since it is important to anticipate the risk of this complica-
tion when deciding on strategies of UBC treatment. The
second purpose was to identify the factors influencing UBC
healing, to aid in deciding treatment for patients with UBC.Methods
UBC patients who consulted 4 Nagoya musculoskeletal on-
cology group hospitals (Nagoya University Hospital, Aichi
Cancer Center Hospital, Aichi Cancer Center Aichi Hos-
pital, Nagoya Memorial Hospital) in Japan between Januaryl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 2 Characteristics and treatments of patients
included in evaluation for healing (n = 141)
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http://www.biomedcentral.com/1471-2474/15/1591988 and February 2011 (n = 168) were collected. Thirteen
patients were not suitable for the purposes of this study
because of a lack of clinical records. One hundred fifty-five
consecutive patients with UBC were retrospectively
reviewed. As our treatment strategy of UBC, a biopsy was
performed in patients in whom the possibility of other con-
ditions was suspected (n = 30). Pathological fractures were
treated as a rule with immobilization. Surgical treatments
were carried out in symptomatic patients, cases predisposed
to fracture, or for bone cysts located in the proximal femur
in which dislocation of the fracture, coxa vera, and avascu-
lar necrosis of the femoral head were major concerns
[12,13].
Baseline patient characteristics are summarized in
Table 1. All 155 patients selected were evaluable for
pathological fracture at presentation, and 141 patients
with follow-up periods over 6 months were evaluable for
UBC healing.
Characteristics and treatments of 141 patients in-
cluded in evaluation of healing are summarized in
Table 2. The median follow up period was 28.7 (range
6.0-178.8) months. Seventy-seven cases were observed
and 64 cases were treated by surgery. In patients of sur-
gery, many of young patients with UBC were treated by
cannulated screws, but various treatment methods were
used for these patients. A biopsy was performed in 30 of
141 patients. Healing of the lesion was defined as healing
of over 50% of the cyst area on X-ray at the last follow
up (Figure 1).Table 1 Baseline characteristics of all patients (n = 155)
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Operative procedure at first time
Cannulated screws 35 (55%)








Median (range) 28.7 (6.0-178.8)Clinical data were collected from the patient’s clinical re-
cords. Chi-square test or Fisher’s exact test and multiple lo-
gistic regression were used to analyze the correlation of
various clinical factors with fracture at presentation or heal-
ing of UBC. Clinical factors such as sex, age (≧20, <20),
sites (long bone or not) (specific bone or not), diameter
(≧5 cm, <5 cm), multilocular, ballooning of bone, and
Figure 1 Healing of UBC. Fifteen-year-old male of UBC in his left distal radius: Anteroposterior radiograph at his first presentation (A) and
12 months later (B). He had a pathological fracture at first visit and complete healing was observed after observation. Ten-year-old male of UBC
in his left proximal humerus: Anteroposterior radiograph after surgery (C) and 4 years 7 months after surgery (D). Partial healing was observed
after surgery of cannulated screw.
Urakawa et al. BMC Musculoskeletal Disorders 2014, 15:159 Page 3 of 9
http://www.biomedcentral.com/1471-2474/15/159cortical thickness (≧2 mm, <2 mm) were analyzed for oc-
currence of fracture at presentation. In addition to these
factors, fractures at presentation, history of biopsy, treat-
ment (observation, surgery), and surgery (placement of can-
nulated screw or not) (single, multiple) were evaluated for
healing of UBC. UBCs in humerus were classified into ac-
tive phase (juxtaposed to the cartilaginous growth plate) or
latent phase (migrating away and separating from the
growth plate) [4], and the phase (active, latent) was evalu-
ated for healing. P-values of <0.05 were considered to indi-
cate significance.
This study was approved by Nagoya university ethics
committee in November, 2012, and the registration
number was 2012–0202. After obtaining a waiver of pa-
tient informed consent requirements from our institu-
tional review board, we conducted a retrospective review
from clinical records.Results
Sixty of 155 patients had pathological fracture at presenta-
tion. In univariate analysis, cyst in long bone (p < 0.001),
diameter more than 5 cm (p < 0.001), multilocular cyst
(p < 0.001), ballooning of bone (p < 0.001), cortical thickness
less than 2 mm (p < 0.001), age less than 20 years
(p = 0.001), and male sex (p = 0.006) were associated with a
significantly increased incidence of pathological fractures at
presentation (Table 3). Forty-three of 55 cases (78%) in hu-
merus, 10 of 35 cases (29%) in femur, 2 of 10 cases (20%) in
pelvis, 1 of 5 cases (20%) in tibia, 1 of 5 cases (20%) in fib-
ula, 1 of 41 cases (2%) in calcaneus, and 2 of 4 cases in
other bones had pathological fracture at presentation. In
univariate analysis, UBC in humerus (43/55; 78%) had sig-
nificantly more fractures than UBC at any other site (17/
100; 17%) (p < 0.001), whereas UBC in calcaneus (1/41; 2%)
had significantly less fracture than at any other site (59/114;
Table 3 Univariate and multivariate analysis of pathological fracture (n = 155)








p = 0.001 n.s. ⁻
≧20 7/41 (17%)
Site
Long bone 55/100 (55%)












p < 0.001 p = 0.011 3.32 (1.31-8.37)
No 11/76 (14%)
Cortex
<2 mm 52/94 (55%)
p < 0.001 p = 0.017 3.36 (1.24-9.13)
≧2 mm 8/61 (13%)
achi-square test and Fisher’s exact test. bmultiple logistic regression. ORc, odds ratio. CId, confidence interval.
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http://www.biomedcentral.com/1471-2474/15/15952%) (p < 0.001). In multivariate analysis, ballooning of
bone (p = 0.011), cyst in long bone (p = 0.012), male sex
(p = 0.013), cortical thickness less than 2 mm (p = 0.017),
and multilocular cyst (p = 0.040) were significant risk fac-
tors for pathological fractures at presentation (Table 3).
One patient with femoral neck UBC developed avascular
necrosis after a displaced pathological fracture, and was
treated by curved intertrochanteric varus osteotomy.
Healing of UBC was less observed in the patients sub-
jected to watchful waiting (23/77; 30%) than in operated
patients (53/64; 83%) at the last follow up (p < 0.001). In
observed patients, fracture at presentation (p = 0.004),
multilocular cyst (p = 0.010), ballooning of bone (p =
0.015), and history of biopsy (p = 0.019) were signifi-
cantly associated with good healing of UBC at the last
follow up in univariate analysis (Table 4). Half of the pa-
tients (14/28 patients) with fracture at presentation and
57% of patients (8/14 patients) after biopsy showed heal-
ing with observation alone at the last follow-up. Five of
these 28 patients were biopsied after fractures, with 4 of
them showing healing at the last follow up. Multivariate
analysis showed that fracture at presentation (p = 0.004)
and history of biopsy (p = 0.013) were independent fac-
tors for good healing in observed patients (Table 4).Healing of UBC was observed in 26 of 35 patients (74%)
after operation with cannulated screw, 12 of 12 patients
(100%) with curettage and graft, 3 of 3 patients (100%)
with curettage, 2 of 3 patients (67%) with drilling, and
10 of 11 patients (91%) with other methods at the last
follow up. There was a statistical significant difference
between cannulated screw and other treatment methods
for healing of UBC (p = 0.046) (Table 5). UBC had
healed in 40 of 50 patients (80%) after single surgery and
in 13 of 14 patients (93%) after multiple surgeries (p =
0.244). In multivariate analysis for healing of UBC in hu-
merus, latent phase UBC (p = 0.011) and treatment with
surgery (p = 0.011) were significantly associated with
good healing of UBC (Table 6). In patients with UBC in
humerus, 3 of 10 patients with active phase and 12 of 21
patients with latent phase were healed at last follow up
with observation (p = 0.152), and 6 of 11 patients with
active phase and 12 of 12 patients with latent phase were
healed after surgery (p = 0.014).
Discussion
This is one of the largest studies to have focused on
UBC in the trunk and extremities. There have been
some clinical series of UBC including some with over
Table 4 Univariate and multivariate analysis for healing of UBC in observed patients (n = 77)








p = 0.088 ⁻ ⁻
≧20 4/24 (17%)
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Long bone 17/50 (34%)












p = 0.015 n.s. ⁻
No 8/43 (19%)
Cortex
<2 mm 17/44 (39%)
p = 0.052 ⁻ ⁻
≧2 mm 6/33 (18%)
Pathological fracture at first visit
Yes 14/28 (50%)




p = 0.019 p = 0.013 5.47 (1.44-20.76)
No 15/63 (24%)
achi-square test and Fisher’s exact test. bmultiple logistic regression. ORc, odds ratio. CId, confidence interval.
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been reported within the past quarter of a century [16].
Previous reports described some clinical factors that
are associated with an increased incidence of patho-
logical fracture with UBC. Radiographic features such as
cyst index (area of the cyst/diaphysis diameter2) [5,7],
percentage of bone occupied by the cyst in the trans-
verse plane [6], and cortical thickness [7] were reported
as prognostic factors of fractures with UBC. Another
report showed that active phase UBC in an upper limb
was at greater risk of fracture [8]. In our study, multi-
variate analysis revealed that ballooning of bone, cyst
in long bone, male sex, thin cortical thickness and
multilocular cyst had a significant impact on increasing
the incidence of pathological fractures at presentation.
There was a possibility that high activity in young males
influenced the high occurrence of pathological fracturein our study. The high occurrence of fracture in balloon-
ing bone, cysts in long bone and thin cortical thick-
ness may reflect the vulnerability of ballooning bone
and mechanical weakness of long bone, and multilocular
UBC were usually observed in wildly spread cysts. In
UBCs of humerus, latent phase significantly promoted
good healing of UBC, with this finding consistent with
previous reports [11]. These cysts at high risk for patho-
logical fractures are clinically problematic and should be
considered for surgery or careful observation.
Most of the pathological fractures were not displaced,
were treated with immobilization, and healed without
other complications, whereas one patient with femoral
neck UBC in this study developed avascular necrosis
after displaced pathological fracture. Some case reports
have described avascular necrosis after pathological frac-
ture in femoral neck UBC, and concluded that every
Table 5 Univariate analysis for healing of UBC after surgery (n = 64)



























<2 mm 36/45 (80%)
p = 0.299
≧2 mm 17/19 (89%)









Placement of cannulated screw 26/35 (74%)
p = 0.046
Others 27/29 (93%)
achi-square test and Fisher’s exact test.
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because of the vascular supply to the upper femoral
epiphysis in childhood and the reported incidence
of avascular necrosis even with undisplaced fracture
[12,13].
The clinical factors associated with good UBC healing
have been reported as fracture [10], small cyst volume
[10], rising cyst index [5], and long distance from the
growth plate [4,11]. In our study, multivariate analysis
showed that fracture at presentation and history of bi-
opsy were good prognostic factors for healing of UBC in
patients under observation, being partially consistent
with the findings of previous reports. An especially inter-
esting finding in our study was the effect of biopsy onhealing of UBC. The diagnosis of UBC is usually not dif-
ficult, but some other lesions, especially in aged patients
and patients after fracture, should be considered in
the differential diagnosis such as primary or secondary
ABC, fibrous dysplasia, non-ossifying fibroma, giant cell
tumor, and osteosarcoma. A previous report showed that
fractured UBCs frequently appear complicated on MR
imaging, with heterogeneous fluid signals and regions of
nodular and thick peripheral enhancement related to
pathologic fracture and early healing [17]. Because some
UBCs did not show typical imaging findings on X-ray or
magnetic resonance imaging, we performed biopsy in
22% of patients. In these patients, 57% of UBC patients
with watchful waiting had healed after biopsy, and a
Table 6 Univariate analysis for healing of UBC in humerus (n = 54)
























p = 0.055 ⁻ ⁻
No 5/13 (38%)
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< 2 mm 28/46 (61%)
p = 0.626 ⁻ ⁻
≧2 mm 5/8 (63%)
Pathological fracture at first visit
Yes 27/43 (63%)








p = 0.026 p = 0.011 6.90 (1.57-30.33)
Observation 15/31 (48%)
achi-square test and Fisher’s exact test. bmultiple logistic regression. ORc, odds ratio. CId, confidence interval.
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able factor for healing in observed patients.
In UBCs of humerus, latent phase significantly pro-
moted good healing of UBC, with this finding consistent
with previous reports [11]. All cysts with latent phase
were healed after surgery, and cysts with latent phase at
high risk for pathological fractures may be good indica-
tion for surgery.
Ahn et al. and Garceau et al. reported that 8% and
15% of UBCs healed after fractures, respectively [6,9],
whereas in our study, 50% of UBCs after fracture healed
without surgical treatment. Five of 28 patients with
watchful waiting after fractures were biopsied, 4 ofwhom showed healing at the last follow up. The high
biopsy rate in our study may have accounted for the
high healing rate after fracture in the observed patients.
The effect of pathological fracture and biopsy may be
similar to that of making multiple holes in surgery [3].
In this study, UBC healing was defined as healing of
the cyst area over 50% on X-ray at the last follow up.
Many of UBC healings were observed in heterogeneous
areas (Figure 1D), and the complete healing rate has been
reported as being relatively low [18]. Since complete
healing is not necessary for prevention of patholo-
gical fracture, we defined cyst healing over 50% as
cyst healing.
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for UBC [15], less invasive methods such as cannulation,
steroid injection, flexible intramedullary nailing, and endo-
scopic surgery have come to be preferred [19-22]. Elastic
intramedullary nailing is the method of choice of treatment
of unicameral bone cysts in children, it was reported to
have the twofold benefits of continuous cyst decompres-
sion, and early immediate stability to the involved bone
segment, which permits early mobilization and return to
the normal activities of the preteen patients [22]. In our
study, healing of UBC was observed in 74% of patients with
cannulation and in 93% after other operations, while treat-
ment with cannulated screw showed a lower healing rate
than other surgical methods in univariate analysis. But this
may not indicate the inferiority of this method for UBC.
Tsuchiya et al. showed a higher success rate of 88% after
treatment with cannulated screw [19]. The primary purpose
of treatment in UBC is the prevention of pathological
fracture, and the less marked invasiveness of cannulation
is consistent with this purpose.
There were some limitations in our study. The first was
the lack of data concerning the recurrence of UBC after
treatment. We analyzed the final results of UBC healing at
the last follow up after a median period of 28.7 (range 6.0-
39.7) months, and did not take any recurrence of UBC into
consideration. The recurrence rate of UBC was reported as
30% at the proximal end of the humerus and 17% at the
proximal end of the femur [14]. Another report showed
that the overall recurrence rate after surgery was 39% in a
long follow up [23], although there was a further possibility
of UBC relapse after the final last follow up. The second
limitation was the evaluation of UBC healing in patients
with multiple surgeries. Healing of UBC was observed in 53
of 64 cases treated surgically, although 13 of 53 patients
healed only after multiple surgeries. We did not evaluate
the effect of additional surgeries on UBC healing. Third,
there was an apparent selection bias between treatment
groups. The healing rates were 30% and 83% with observa-
tion and surgery, respectively, but a simple comparison was
difficult to make because the two groups were not homoge-
neous. Finally, this study included various types of UBC,
both pediatric and adult cases, long bone and others, and
observed and operated cases. Especially this study included
41 of 155 cases of adult cases, but most of these were
young adult and some of adult cases were pathologic-
ally diagnosed.
Conclusions
In conclusion, ballooning of bone, cyst in long bone, male
sex, thin cortical thickness and multilocular cyst were
significant adverse prognostic factors for pathological
fractures, whereas fracture at presentation and history of
biopsy were favorable prognostic factors for healing of UBC
in patients under observation. These clinical factors may beuseful for deciding treatment in patients with UBC. A his-
tory of mechanical disruption of UBC such as fracture and
biopsy seems to be good indication for watchful waiting,
but patients with some poor prognostic factors of fractures
or with UBC in the femur should be treated with surgery.
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